Feature Channels:

Autoimmune Diseases

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

encefalitis, autoinmunitaria

Cuando el cuerpo ataca al cerebro: El sistema inmunitario generalmente es el culpable de la encefalitis, descubre estudio

La encefalitis causada por el ataque del sistema inmunitario al cerebro tiene una frecuencia similar a la de la encefalitis producto de infecciones, informan los investigadores de Mayo Clinic en los Anales de Neurología.

Medicine

Channels:

Autoimmune, Encephalitis

When the Body Attacks the Brain: Immune System Often to Blame for Encephalitis, Study Finds

ROCHESTER, Minn. — Encephalitis caused by the immune system attacking the brain is similar in frequency to encephalitis from infections, Mayo Clinic researchers report in Annals of Neurology.

Medicine

Channels:

Neuropathic, neuropathic pain conditions, peripheral nerves, autoimmunde disorders, Myelin Sheath, Nature Medicine, Cincinnati Children's Hospital Medical Center, Research, Pediatrics, news, press release

Experimental Therapy Restores Nerve Insulation Damaged by Disease

LuNatureMedicine.jpg

When the body attacks its own healthy tissues in an autoimmune disease, peripheral nerve damage handicaps people and causes persistent neuropathic pain when insulation on healing nerves doesn’t fully regenerate. Unfortunately, there are no effective ways to treat the condition. Now scientists describe in Nature Medicine an experimental molecular therapy that restores insulation on peripheral nerves in mice, improves limb function, and results in less observable discomfort.

Medicine

Channels:

Modified Drug Shows Promise, Patterns in Vietnam, Phone-Delivered Therapy, and More in the AIDS and HIV News Source

The latest research, features, and experts on HIV and AIDS.

Medicine

Channels:

Vasculitis Foundation Establishes “VF Bob Day” February 1, 2018; Celebrating Longtime Volunteer’s Contributions with Global Awareness Initiative

VFBob_rs.jpg

VF Bob is a new campaign launched by the Vasculitis Foundation to honor the late Bob Sahs, one of the organization's greatest awareness advocates. The goal of the campaign is to both spread awareness about autoimmune vasculitis, and to promote the work of the Vasculitis Foundation to support patients and fund research into vasculitis.

Medicine

Channels:

biosimilar, American College Of Rhematology (Acr), Health And Human Services, Merit-Based Incentive Payment System, Part B Drugs

Rheumatology Leaders to HHS: Prior Authorization, Recent Part B Payment Change are Biggest Threats to Healthcare Choice and Competition

The ACR urged HHS to reform its prior authorization policies, to reverse a recent HHS decision to apply Part B drug spending to payment adjustments under the Merit-Based Incentive Payment System (MIPS); require pharmacy benefit managers (PBMs) to be more transparent; and continue supporting biosimilar innovation.

Medicine

Channels:

Infant Sleep Practices, Nonmedicated ADHD Treatments, Blood Infections, and More in the Children's Health News Source

Click here for the latest research and features on Children's Health.

Medicine

Science

Channels:

Neurogastronomy, After Surgical Weight Loss, Probiotic Akkermansia and More in the Obesity News Source

Click here to go directly to Newswise's Obesity News Source

Medicine

Channels:

Thryoid, Hypothyroid, Hypothyroidism, Hyperthyroid, Hyperthyroidism, Graves Disease, Autoimmune Disease

Hyperthyroidism vs. Hypothyroidism: What's the Difference?

Camacho_P_MD_08_23_00.jpg

Loyola's Pauline Camacho, MD, Offers Tips for National Thyroid Awareness Month

Medicine

Channels:

Scleroderma, University Of Virginia, UVA, University of Virginia Cancer Center, UVA Cancer Center, NCI-designated cancer centers, Cancer, Karen Ballen, University of Virginia School of Medicine, UVA School of Medicine, autoimmune disorder, Autoimmune Disease, skin, Skin Disorder, skin thickening, skin hardening, New Treatments, Medical Research, treatment f

Scleroderma: Study Suggests Hope for Longer Life for Patients with Rare Autoimmune Disorder

BallenKaren-email.jpg

The approach could represent the first new treatment to improve survival in patients with severe scleroderma in more than four decades.







Chat now!